Supernus Pharmaceuticals, Inc.
NASDAQSUPN cost to borrow surges 131.75% to 0.43% over one week, though remains low in absolute terms; short interest slides 20% as availability balloons to 3,938% of SI.
Snapshot as of 23 Sept 2026
No long-form analysis yet for SUPN. Pulse alerts and the live data picture are available on ORTEX.
Open SUPN on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SUPN — free to start on ORTEX.
Sign up for free →Open SUPN on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live SUPN data →